CAFs activated by Egfl7 through the ανβ3 integrin signaling pathway could further remodel the tumour microenvironment and in turn facilitate HCC cell proliferation, invasion and metastasis. The gene discussed is EGFL7; the disease is hepatocellular carcinoma.